The pharmaceutical water market involves the use of highly purified water in various pharmaceutical applications such as sterile manufacturing, oral and injectables manufacturing. Pharmaceutical water finds extensive usage in active pharmaceutical ingredients manufacturing, cleaning of equipment and facilities and also in formulation of finished drugs. It helps maintain quality of drugs and ensures safety of patients. The global pharmaceutical water market size is estimated to be valued at US$ 7.22 Bn in 2024 and is expected to exhibit a CAGR of 11% over the forecast period between 2024 to 2031.
Key Takeaways
Key players operating in the pharmaceutical water market are Heidelberg Printing Machinery AG, Komori Corporation, Koenig & Bauer AG, Manroland Goss web systems, HP Inc., Xerox Corporation, Canon Inc., Ricoh Company, Ltd., Epson, Konica Minolta, Inc. The stringent regulations laid down by various regulatory bodies is driving the demand for pharmaceutical grade water significantly. With growth in generic drugs market and rise of contract manufacturing, the demand for highly purified and controlled water is on the rise. The companies are expanding their presence globally especially in emerging markets of Asia Pacific and Latin America to tap new growth opportunities.
Market Drivers
One of the major drivers propelling the growth of pharmaceutical water market is the stringent regulatory standards laid down by various regulatory bodies such as USFDA, EMA, WHO etc. for using highly purified water in all pharmaceutical applications and manufacturing processes. These standards aim to control quality of water to ensure safety of patients. Non-compliance may result in huge penalties, product recalls or facility shutdowns forcing companies to use purified and controlled water to meet quality guidelines. This is positively impacting the market growth.
Current geopolitical situations are impacting the growth of the Pharmaceutical Water Market Demand. The Russia-Ukraine war has caused disruptions to supply chains and trade of APIs and other pharmaceutical intermediates. Many European countries are dependent on Russia and Ukraine for pharmaceutical intermediates and active ingredients. The ongoing conflict has stressed supply networks and increased costs. Additionally, the COVID-19 pandemic highlighted disparities in healthcare infrastructure across the world. It brought focus on the need for reliable water treatment in the pharmaceutical industry. Proper treatment of water is critical for drug manufacture to achieve hygienic standards. With changes in disease patterns and rising burden of non-communicable diseases across regions, the demand for new drug development is increasing. This is creating opportunities for integrated water management systems in pharmaceutical facilities. However, currency fluctuations and restrictions can constrain market potential in some parts of the world. Overall, geopolitical dynamics underscore the requirement of alternate sourcing, local manufacturing and strategic global alliances to mitigate risks for the pharmaceutical water market.
In terms of value, North America holds the major share of the pharmaceutical water market currently owing to stringent regulatory norms and established healthcare infrastructure. The presence of leading pharmaceutical companies and advanced water treatment facilities supports market growth. Asia Pacific is rapidly emerging as the fastest growing regional market. This can be attributed to increasing generic drug manufacturing, rising contract services and expanding R&D activities in countries like India and China. Low manufacturing costs and proactive government policies are drawing investments towards Asia. Europe also captures a substantial market share and continues to invest in new water purification technologies for the pharmaceutical sector. Meanwhile, political uncertainties and inadequacies in healthcare access remain challenges for market expansion across Middle East, Africa and Latin America.
Get more insights on Pharmaceutical Water Market
